Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharma Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel synthetic route for Cephanolide B using Negishi coupling and Pd-catalysis. Offers cost reduction and scalable supply for pharma R&D teams.
Patent CN110054603A details a novel Pd-catalyzed C-H activation method for aryl C-glycosides, offering significant supply chain stability and cost efficiency for pharmaceutical manufacturing.
Novel phase transfer catalysis method for p-chlorophenylglycine improves yield and purity for pharmaceutical intermediates manufacturing supply chain efficiency and cost.
Patent CN106589015A reveals optimized Tribenoside synthesis reducing waste and improving purity. Enables cost reduction in pharmaceutical intermediates manufacturing and supply chain reliability.
Patent CN118546096A reveals a novel Pd-catalyzed route for chiral tetrahydropyridazines, offering significant cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN109776384B reveals a one-step Rh-catalyzed synthesis of complex bis-quaternary carbon oxindoles, offering significant cost reduction in API manufacturing and high atom economy.
Novel synthetic route for Cephanolide C via patent CN108129432B. Offers scalable manufacturing and cost reduction for pharmaceutical intermediates supply chains.
Novel patent CN117820194A details a palladium-free route for high-purity indole intermediates. Offers significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN109824562A reveals a green lactic acid catalyzed route. Achieve high purity and cost reduction in fine chemical manufacturing with scalable processes.
Novel patent CN117820194A offers palladium-free synthesis. Enhances supply chain reliability and cost reduction in pharmaceutical intermediates manufacturing.
Patent CN100338039C details a novel Lewis acid-catalyzed synthesis for S/R-Ornidazole. This method ensures >99.5% purity, offering significant cost reduction and scalable supply chain solutions for global pharmaceutical manufacturers.
Patent CN109824562A reveals ultrasonic lactic acid catalysis for high-purity intermediates. Offers significant cost reduction and supply chain reliability for global buyers.
Patent CN105368913A reveals dual-enzyme immobilization for chiral amino acids. Offers high purity and scalable manufacturing for pharmaceutical intermediates.
Patent CN109824562A reveals lactic acid catalyzed synthesis. High purity, reduced waste, scalable for pharmaceutical intermediate supply chains and cost effective production.
Patent CN105368913A reveals dual-enzyme immobilization for high-purity chiral unnatural amino acid production with significant cost and supply chain advantages.
Patent CN1053431A reveals an advanced method for Fosinopril synthesis, offering improved stereoselectivity and cost reduction in pharmaceutical intermediate manufacturing for global supply chains.
Advanced Fmoc solid-phase synthesis for Triptorelin bulk drug. Patent CN103012565A offers high yield, low racemization, and scalable manufacturing for reliable supply chains.
Patent CN113698458A details a full liquid-phase method for triptorelin, offering high purity crude product and significant cost reduction in peptide manufacturing compared to solid-phase routes.
Patent CN107417724B reveals a novel Ru-SPO catalyst achieving 99% selectivity. Discover cost-effective solutions for chiral pharmaceutical intermediate manufacturing.
Patent CN105693696A reveals efficient synthesis of aminopyrazolyldipyridine ligands. Enables cost reduction in pharmaceutical intermediate manufacturing with high purity.